RXI PHARMACEUTICALS CORPORATION

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 27140
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 22233
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1188
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0030,451 METHODS FOR TREATING AGING AND SKIN DISORDERS USING NUCLEIC ACIDS TARGETING TYR OR MMP1Sep 04, 15Feb 01, 18[A61K, C12N]
2017/0051,290 METHODS FOR TREATMENT OF DISORDERS IN THE FRONT OF THE EYE UTILIZING NUCLEIC ACID MOLECULESMay 01, 15Feb 23, 17[A61K, C12N]
2017/0043,024 BIOACTIVE CONJUGATES FOR OLIGONUCLEOTIDE DELIVERYAug 12, 16Feb 16, 17[A61K, C12N]
2016/0319,278 FULLY STABILIZED ASYMMETRIC SIRNAApr 01, 16Nov 03, 16[C12N]
2016/0304,873 Immunotherapy of CancerDec 02, 14Oct 20, 16[C12N]
2016/0304,875 METHODS FOR TREATMENT OF WOUND HEALING UTILIZING CHEMICALLY MODIFIED OLIGONUCLEOTIDESDec 04, 14Oct 20, 16[A61K, C12N]
2016/0244,765 REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDSSep 25, 15Aug 25, 16[C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9862952 Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disordersApr 01, 16Jan 09, 18[A61K, C12N]
9809817 Oligonucleotide compounds for targeting huntingtin mRNAApr 01, 16Nov 07, 17[A61K, C12N]
9745574 RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionalityFeb 04, 10Aug 29, 17[A61K, C12N]
9493774 Inhibition of PCSK9 through RNAiJan 05, 10Nov 15, 16[C07H, C12N]
9340786 RNA interference in dermal and fibrotic indicationsMar 24, 11May 17, 16[A61K, C07H, C12N]
9303259 RNA interference in skin indicationsDec 12, 13Apr 05, 16[A61K, C12N]
9175289 Reduced size self-delivering RNAi compoundsMay 15, 14Nov 03, 15[C07H, A61K, C12N]
9095504 RNA interference in ocular indicationsMar 24, 11Aug 04, 15[A61K, C12N]
9074211 Inhibition of MAP4K4 through RNAINov 19, 09Jul 07, 15[C12N]
8946180 Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identificationJun 11, 12Feb 03, 15[A61K, C07H]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0105,448 MEANS AND METHODS FOR THE SPECIFIC MODULATION OF TARGET GENES IN THE CNS AND THE EYE AND METHODS FOR THEIR IDENTIFICATIONAbandonedDec 19, 14Apr 16, 15[C12N]
2013/0039,971 COMPOSITIONS AND METHODS FOR INHIBITION OF VEGFAbandonedJul 23, 12Feb 14, 13[A61K, C07H, A61P, A61N]
2011/0268,761 Effective Sensitizing Dose of a Gelled Immunomodulating Topical CompositionAbandonedFeb 25, 11Nov 03, 11[A61K, A61P]
2011/0251,258 RNAI CONSTRUCTS AND USES THEREOFAbandonedJul 23, 09Oct 13, 11[A61K, C07H]
2011/0143,400 SIRNA AND METHODS OF MANUFACTUREAbandonedDec 15, 10Jun 16, 11[C07H, C12P]
2011/0021,605 MEANS AND METHODS FOR THE SPECIFIC INHIBITION OF GENES IN CELLS AND TISSUE OF THE CNS AND/OR EYEAbandonedJul 01, 10Jan 27, 11[A61K, C12Q, A01K, A61P]
2010/0069,620 NOVEL COMPOSITIONS OF CHEMICALLY MODIFIED SMALL INTERFERING RNAAbandonedJan 23, 07Mar 18, 10[C07H]
2009/0131,360 Tripartite RNAi constructsAbandonedOct 02, 08May 21, 09[A61K]
2008/0152,654 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESISAbandonedJun 12, 07Jun 26, 08[A61K, A61P]
2007/0178,068 COMPOSITIONS AND METHODS FOR REGULATING COMPLEMENT SYSTEMAbandonedDec 22, 06Aug 02, 07[A61K, C07H]
2005/0222,061 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eyeAbandonedApr 18, 05Oct 06, 05[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.